Title:
セルトラリン組成物
Document Type and Number:
Japanese Patent JP2007502329
Kind Code:
A
Abstract:
An acid salt of sertraline, wherein the acid is citric acid, fumaric acid, malic acid, maleic acid, malonic acid, phosphoric acid, succinic acid, sulfuric acid, L-tartaric acid, HBr, acetic acid, benzoic acid, benzenesulfonic acid, ethanesulfonic acid, lactic acid, methanesulfonic acid or toluenesulfonic acid. Similarly, a solvate of sertraline HCl, wherein the solvent is methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, t-butanol, acetic acid, ethyl acetate, or propylene glycol.
More Like This:
Inventors:
Remenor, Julius
Michael McAfee
Matthew Peterson
Tawa mark
Michael McAfee
Matthew Peterson
Tawa mark
Application Number:
JP2006533309A
Publication Date:
February 08, 2007
Filing Date:
May 21, 2004
Export Citation:
Assignee:
TRANSFORM PHARMACEUTICALS, INC.
International Classes:
C07C211/42; A61K31/135; A61K31/205; A61P1/14; A61P3/04; A61P5/24; A61P15/00; A61P17/02; A61P17/06; A61P19/02; A61P25/18; A61P25/22; A61P25/24; A61P25/30; A61P29/00; A61P37/06; B01D9/02; C07B53/00; C07C53/08; C07C55/08; C07C55/10; C07C57/145; C07C57/15; C07C59/245; C07C59/255; C07C59/265; C07C63/06; C07C209/68; C07C211/62; C07C215/34; C07C309/04; C07C309/29; C07C309/30; A61K47/04; A61K47/12; A61K47/20; A61K47/48
Attorney, Agent or Firm:
Shinki Global IP Patent Corporation